SCHEMBL292318

SCHEMBL292318

CCCCc1ccc(OC)c(O)c1CCCC

nearest known ligand 0.57

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 11/20 0.57
PTGS2 P35354 4/20 0.57
ELANE P08246 3/20 0.47
CTSG P08311 1/20 0.47
TYR P14679 2/20 0.44
PTGES O14684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26929508 0.86 ALOX5 (0.57) ALOX5PTGS2ELANECTSGTYR
SCHEMBL515723 0.86 ALOX5 (0.65) ALOX5PTGS2ELANECTSGTYR
SCHEMBL4538252 0.82 ALOX5 (0.69) ALOX5PTGS2ELANECTSGTYR
SCHEMBL1005744 0.81 TYR (0.56) ALOX5PTGS2ELANECTSGTYR
SCHEMBL5586648 0.81 TYR (0.40) ALOX5PTGS2ELANECTSGTYR
Gallic Acid SCHEMBL7539623 0.80 PTGS2 (0.50) ALOX5PTGS2
SCHEMBL29452317 0.79 HMGCR (0.47) ALOX5PTGS2ELANEPTGES
SCHEMBL12439989 0.79 ALOX5 (0.41) ALOX5PTGS2ELANECTSGTYR
SCHEMBL26046491 0.79 HMGCR (0.47) ALOX5PTGS2ELANEPTGES
SCHEMBL31621741 0.79 ALOX5 (0.53) ALOX5PTGS2ELANECTSGTYR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 312 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118831168-A Ophthalmic composition with cooling sensation and preparation method and application thereof 深圳市眼学科技有限公司 2024-10-25 CN claimed
CN-111526892-B Ophthalmic product and masking method 狮王株式会社 2024-03-22 CN claimed
WO-2023185761-A1 TRETINOIN AND BENZOYL PEROXIDE COMPOSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF 南京毓浠医药技术有限公司 2023-10-05 WO claimed
CN-108603022-B Polyalkylene oxide compositions 住友精化株式会社 2023-03-28 CN claimed
CN-106687138-B Vaccine pharmaceutical composition for cellular immunization comprising bisphosphonate agent 日东电工株式会社 2021-10-15 CN claimed
CN-109835080-B Single-coating direct-machining treatment-free CTP (computer to plate) 安徽强邦新材料股份有限公司 2021-10-08 CN claimed
US-11046631-B2 Diphenol and phenol prills and method for obtaining the same RHODIA OPERATIONS (FR) 2021-06-29 US claimed
US-10925936-B2 Vaccine pharmaceutical composition for cell-mediated immunity containing bisphosphonates NITTO DENKO CORPORATION (JP) 2021-02-23 US claimed
EP-3544946-B1 DIPHENOL PRILLS AND METHOD FOR OBTAINING THE SAME RHODIA OPERATIONS (FR) 2021-01-06 EP claimed
CN-111526892-A Ophthalmic product and masking method 狮王株式会社 2020-08-11 CN claimed
EP-3189854-A1 VACCINE PHARMACEUTICAL COMPOSITION FOR CELL-MEDIATED IMMUNITY CONTAINING BISPHOSPHONATES Nitto Denko Corporation (JP) 2017-07-12 EP claimed
CN-103700800-B A kind of lithium ion battery separator manufacture method Changsha University of Sciences and Technology (CN) 2016-02-17 CN claimed
CN-101962529-B Soybean protein-calcium carbonate nano-adhesive as well as preparation method and application thereof UNIV NANJING INF SCI & TECH 2012-06-13 CN claimed
CN-101962529-A Soybean protein-calcium carbonate nano-adhesive as well as preparation method and application thereof UNIV NANJING INF SCI & TECH 2011-02-02 CN claimed
EP-0743011-B1 PROCESSED MEAT, MEAT MATERIAL USING THE SAME, AND METHOD OF PROCESSING MEAT KATAYAMA KK (JP) 2004-03-31 EP claimed
US-6352685-B2 COMPRISING EXTRACT OF PUERARIA MIRIFICA, WHITENING AGENT, ANTI-OXIDANT, ANTI-INFLAMMATION AGENT, ULTRAVIOLET-RAY SHIELDING INGREDIENT KOSé CORPORATION (JP) 2002-03-05 US claimed
US-20010014311-A1 External preparation for skin SHIRATORI PHARMACEUTICAL CO., LTD. (JP) 2001-08-16 US claimed
CN-1301543-A Skin external use agent KOSE CORP (JP) 2001-07-04 CN claimed
EP-0743011-A1 PROCESSED MEAT, MEAT MATERIAL USING THE SAME, AND METHOD OF PROCESSING MEAT Kabushiki Kaisha Katayama (JP) 1996-11-20 EP claimed
US-5143763-A OXYGEN SCAVENGER TORAY INDUSTRIES, INC. (JP) 1992-09-01 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11046631-B2 Diphenol and phenol prills and method for obtaining the same DPM1, MCOLN3, TYR ALOX5 1644/4885PTGS2 778/4885ELANE 1735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.